UK Parliament / Open data

Dangerous Drugs

Proceeding contribution from Dan Poulter (Conservative) in the House of Commons on Tuesday, 12 September 2023. It occurred during Debates on delegated legislation on Dangerous Drugs.

It is a pleasure to follow the SNP spokesperson, the hon. Member for Glasgow Central (Alison Thewliss). I do not disagree with much of what she said. I believe the Government will achieve very little through these measures, except perhaps to cause considerable disruption to industry and the medicinal use of nitrous oxide. I am far from convinced by the changing reassurances given by the Minister at the Dispatch Box in that respect.

I once again draw the attention of the House to my entry in the Register of Members’ Financial Interests. I am a practising NHS psychiatrist. Until recently, I was working as an acting addictions consultant psychiatrist and I have dealt with the misuse of drugs extensively throughout my medical career.

I believe in an evidence-based approach to policymaking. This issue has been examined by the ACMD at the request of the Government. The ACMD suggested very clearly that this was not the appropriate legislative vehicle to deal with nitrous oxide. It made that recommendation for two reasons. First, we already have the Psychoactive

Substances Act 2016, so if we want to deal with the illegitimate sale and supply of nitrous oxide there is already legislation in place to do that. Secondly, we have other laws that can be used, for example to deal with the unacceptable littering that sometimes occurs with the canisters used in the recreational use of nitrous oxide.

Type
Proceeding contribution
Reference
737 cc857-8 
Session
2022-23
Chamber / Committee
House of Commons chamber
Back to top